Evidence map›Paper›PMID 41708589›Full record

ArticleCell death & disease2026

ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression.

Zu-Hui Xu, Jie Chen, Ying He, Cheng Lei, Xiao-Ling Wang, De-Fa Huang, Zheng-Zhe Li, Hui Zhou, Mei-Yan Wang, Cheng-Gui Song and 4 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zu-Hui Xu *Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Jie Chen *Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Ying He *Laboratory Animal Research Center, Xiamen University, Xiamen, Fujian, China.
Cheng LeiState Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China.
Xiao-Ling WangDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
De-Fa HuangDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Zheng-Zhe LiDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Hui ZhouDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Mei-Yan WangThe First School of Clinical Medicine, Gannan Medical University, Ganzhou, Jiangxi, China.
Cheng-Gui SongThe First School of Clinical Medicine, Gannan Medical University, Ganzhou, Jiangxi, China.
Juan LinState Key Laboratory of Cellular Stress Biology, Cancer Research Center, School of Medicine, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China. linjuan2020@xmu.edu.cn.ORCID http://orcid.org/0009-0005-1321-5793
Wen LiuState Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China. w2liu@xmu.edu.cn.ORCID http://orcid.org/0000-0003-3434-4162
Xiao-Nan WuState Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China. xnwu@xmu.edu.cn.ORCID http://orcid.org/0000-0003-1887-8383
Wen-Juan ZhangDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China. wjzhang_kyuu@gmu.edu.cn.ORCID http://orcid.org/0000-0001-5434-5192

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of enhancer activity plays a pivotal role in governing gene expression and cellular behaviors. However, the precise mechanisms underlying dynamic control of active enhancers remain incompletely defined. Here, we demonstrate that the nuclear receptor estrogen-related receptor α (ERRα) forms a functional complex with the H3K4me3-specific demethylase KDM5C to co-occupy a large set of active enhancers, including the locus of STING. In breast cancer cells, ERRα depletion induces STING enhancer hyperactivation, evidenced by H3K4me3 deposition, decreased H3K4me1, and increased enhancer RNA (eRNA) transcription. Accordingly, depletion of ERRα leads to further activation of STING gene transcription and TBK1-IRF3 pathway, accompanied by increased type I interferon (IFN) and IFN-stimulated gene (ISG) expression, as confirmed by transcriptomic analysis. Notably, depleting ERRα markedly attenuates breast tumor cell growth in vitro and in vivo, and our in vitro evidence indicates this occurs in part through activating STING signaling. These findings establish that the ERRα-KDM5C serves as a critical checkpoint for STING enhancer activity, revealing a regulatory mechanism of STING enhancer activity in breast tumor progression.

Indexed as

Breast NeoplasmsEnhancer Elements, GeneticInterferon Type IMembrane ProteinsReceptors, EstrogenAnimalsCell Line, TumorcGAS-STING Signaling PathwayDisease ProgressionERRalpha Estrogen-Related ReceptorFemaleGene Expression Regulation, NeoplasticHumansInterferon Regulatory Factor-3MiceProtein Serine-Threonine KinasesERRalpha Estrogen-Related ReceptorInterferon Regulatory Factor-3Interferon Type IMembrane ProteinsProtein Serine-Threonine KinasesReceptors, EstrogenSTING1 protein, humanSTING Protein

Identifiers

PMID41708589
PMCPMC12920621

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.